Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 11 - 04 tags : Trial save search
Keros Therapeutics to Present at the 63rd American Society of Hematology Annual Meeting and Exposition, Including Presenting Additional Data from its Phase 2 Clinical Trial Evaluating KER-050 in Patients with Myelodysplastic Syndromes
Published: 2021-11-04 (Crawled : 02:00) - biospace.com/
KROS | $56.135 1.71% 1.68% 260K
|
Health Technology
|
| O: -1.64%
H: 0.0%
C: 0.0%
ema phase 2 trial syndros
Gates Industrial to Participate in Baird's 2021 Global Industrial Conference
Published: 2021-11-04 (Crawled : 22:00) - prnewswire.com
GIC | $40.96 -0.82% 0.0% 57K
|
Retail Trade
|
| O: 2.66%
H: 0.0%
C: 0.0%
MS | News 0 d | $93.85 0.1% 0.0% 4.8M
|
Finance
|
| O: -0.9%
H: 0.0%
C: 0.0%
GTES | $17.77 0.68% 0.0% 1.4M
|
Producer Manufacturing
|
| O: 1.14%
H: 0.0%
C: 0.0%
trial conference
Graphite Bio Announces Presentation on Phase 1/2 CEDAR Trial of GPH101 in Sickle Cell Disease at Upcoming 63rd ASH Annual Meeting and Exposition
Published: 2021-11-04 (Crawled : 21:00) - biospace.com/
GRPH 4 | $3.27 1.84% 490K
|
Professional, Scientific, and T...
|
| O: 0.38%
H: 2.12%
C: -3.71%
presentation disease phase 1 trial
Results from PROTECT Trial Evaluating KRYSTEXXA® (pegloticase injection) in Kidney Transplant Recipients with Uncontrolled Gout Presented as Part of American Society of Nephrology (ASN) Kidney Week
Published: 2021-11-04 (Crawled : 18:00) - biospace.com/
HZNP | $116.3 0.03% 29M
|
Health Technology
|
| O: -0.74%
H: 0.93%
C: -3.87%
injection results trial kidney
Eyenovia Announces First Patient Enrolled in Phase 3 VISION-2 Trial of MicroLine for Presbyopia
Published: 2021-11-04 (Crawled : 17:00) - eyenoviabio.com
EYEN | $0.5897 8.68% 7.99% 770K
|
Health Technology
|
| O: 5.78%
H: 0.0%
C: -3.8%
eye phase 3 trial enroll 8 billion market presbyopia
Allogene Therapeutics to Showcase Clinical Data from the ALPHA, ALPHA2 and UNIVERSAL AlloCAR T™ Trials at the 63rd Annual Meeting of the American Society of Hematology
Published: 2021-11-04 (Crawled : 15:15) - globenewswire.com
ALLO | $3.04 -9.79% -10.86% 2.1M
|
Health Technology
|
| O: 4.4%
H: 0.0%
C: 0.0%
ema trials trial
CSX Chief Executive Officer to Address Baird Global Industrial Conference
Published: 2021-11-04 (Crawled : 15:15) - globenewswire.com
GIC | $40.96 -0.82% 0.0% 57K
|
Retail Trade
|
| O: -0.94%
H: 0.0%
C: 0.0%
CSX | News | $33.65 -3.08% -3.18% 24M
|
Transportation
|
| O: -0.53%
H: 0.73%
C: -0.17%
trial conference
Tenable Named a Leader in Industrial Control Systems Security by Independent Research Firm
Published: 2021-11-04 (Crawled : 14:00) - globenewswire.com
TENB | $46.4 0.54% 0.54% 550K
|
Technology Services
|
| O: 0.79%
H: 1.12%
C: 0.64%
security research trial
Actinium Announces Completion of Enrollment of Actimab-A CLAG-M Combination Trial in Patients with Relapsed or Refractory Acute Myeloid Leukemia Fit for Induction Therapy
Published: 2021-11-04 (Crawled : 13:00) - prnewswire.com
ATNM | $7.06 1.44% 0.0% 150K
|
Health Technology
|
| O: 7.4%
H: 0.77%
C: -7.99%
myeloid leukemia therapy leukemia trial enroll acute myeloid leukemia
Tecnoglass to Attend the Baird 51st Annual Global Industrial Conference
Published: 2021-11-04 (Crawled : 13:00) - globenewswire.com
GIC | $40.96 -0.82% 0.0% 57K
|
Retail Trade
|
| O: -0.94%
H: 0.0%
C: 0.0%
TGLS | $55.9 -0.07% 0.0% 140K
|
Producer Manufacturing
|
| O: 1.02%
H: 1.35%
C: 0.84%
glass trial conference
Bicycle Therapeutics Announces First Patient Dosed in Phase I/II Trial of Bicycle® Tumor-targeted Immune Cell Agonist™ BT7480 in Patients with Advanced Solid Tumors Associated with Nectin-4 Expression
Published: 2021-11-04 (Crawled : 11:00) - biospace.com/
BCYC | $22.7 0.09% 0.09% 520K
|
Health Technology
|
| O: 1.79%
H: 0.86%
C: -0.05%
solid tumors trial
STAG Industrial Announces Pricing of Public Offering of Common Stock
Published: 2021-11-04 (Crawled : 03:00) - stagindustrial.com
STAG | $34.75 -1.86% 0.0% 1.6M
|
Finance
|
| O: -1.87%
H: 0.14%
C: -0.75%
offering trial publication
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.